Skip to main content

Site navigation

  • University of Technology Sydney home
  • Home

    Home
  • For students

  • For industry

  • Research

Explore

  • Courses
  • Events
  • News
  • Stories
  • People

For you

  • Libraryarrow_right_alt
  • Staffarrow_right_alt
  • Alumniarrow_right_alt
  • Current studentsarrow_right_alt
  • Study at UTS

    • arrow_right_alt Find a course
    • arrow_right_alt Course areas
    • arrow_right_alt Undergraduate students
    • arrow_right_alt Postgraduate students
    • arrow_right_alt Research Masters and PhD
    • arrow_right_alt Online study and short courses
  • Student information

    • arrow_right_alt Current students
    • arrow_right_alt New UTS students
    • arrow_right_alt Graduates (Alumni)
    • arrow_right_alt High school students
    • arrow_right_alt Indigenous students
    • arrow_right_alt International students
  • Admissions

    • arrow_right_alt How to apply
    • arrow_right_alt Entry pathways
    • arrow_right_alt Eligibility
arrow_right_altVisit our hub for students

For you

  • Libraryarrow_right_alt
  • Staffarrow_right_alt
  • Alumniarrow_right_alt
  • Current studentsarrow_right_alt

POPULAR LINKS

  • Apply for a coursearrow_right_alt
  • Current studentsarrow_right_alt
  • Scholarshipsarrow_right_alt
  • Featured industries

    • arrow_right_alt Agriculture and food
    • arrow_right_alt Defence and space
    • arrow_right_alt Energy and transport
    • arrow_right_alt Government and policy
    • arrow_right_alt Health and medical
    • arrow_right_alt Corporate training
  • Explore

    • arrow_right_alt Tech Central
    • arrow_right_alt Case studies
    • arrow_right_alt Research
arrow_right_altVisit our hub for industry

For you

  • Libraryarrow_right_alt
  • Staffarrow_right_alt
  • Alumniarrow_right_alt
  • Current studentsarrow_right_alt

POPULAR LINKS

  • Find a UTS expertarrow_right_alt
  • Partner with usarrow_right_alt
  • Explore

    • arrow_right_alt Explore our research
    • arrow_right_alt Research centres and institutes
    • arrow_right_alt Graduate research
    • arrow_right_alt Research partnerships
arrow_right_altVisit our hub for research

For you

  • Libraryarrow_right_alt
  • Staffarrow_right_alt
  • Alumniarrow_right_alt
  • Current studentsarrow_right_alt

POPULAR LINKS

  • Find a UTS expertarrow_right_alt
  • Research centres and institutesarrow_right_alt
  • University of Technology Sydney home
Explore the University of Technology Sydney
Category Filters:
University of Technology Sydney home University of Technology Sydney home
  1. home
  2. arrow_forward_ios ... Newsroom
  3. arrow_forward_ios ... 2023
  4. arrow_forward_ios 06
  5. arrow_forward_ios Anamorelin for anorexia in lung cancer trial protocol published | IMPACCT news

Anamorelin for anorexia in lung cancer trial protocol published | IMPACCT news

23 June 2023

The LUANA (LUng cancer ANamorelin Anorexia) trial protocol has been published: Phase II study of anamorelin for anorexia in people with lung cancer.

Young woman with short hair sits in front of window. She is wearing a bath robe and looking out the window, which has frosted glass.

Loss of appetite (anorexia) is experienced by most people with lung cancer during the course of their disease and treatment. It is a major contributor to weight loss and can lead to impaired physical capacity and reduced ability of people to cope with and complete their cancer treatment. Despite this, effective and long-term treatments of cancer-associated anorexia are lacking and it remains an area of ongoing clinical need. 

Anamorelin HCl is an orally-active selective-ghrelin receptor agonist which has shown appetite-stimulating effects. Several randomised, double-blind, clinical trials in cancer patients have shown that anamorelin HCl safely reversed muscle loss, augmented body weight, improved appetite, and was well tolerated. Nonetheless, these data were not sufficiently demonstrated to inform a registration of anamorelin by regulatory authorities. By contrast to the other studies conducted to date, this study will focus on anorexia, and on informative and clinically relevant endpoints, including the ability to tolerate anti-cancer therapies.

The investigators propose to test anamorelin HCI administered daily for 12 weeks in people with anorexia and lung cancer in this phase II, double-blind, placebo-controlled, parallel-arm, fixed-dose, multi-site study. The establishment of feasibility, desirability and the qualitative data from this study will inform the conduct of a subsequent robust effectiveness phase III trial. 

The LUANA trial protocol is registered at the Australian New Zealand Clinical Trials Registry [ACTRN12622000129785] and has been published in PLoS One where it can be freely accessed by readers across the globe (10.1371/journal.pone.0285850). 

The authors hypothesise that, “Considering the unmet clinical need for safe and effective treatments for anorexia, anamorelin has the potential to improve anorexia and consequently, improve weight loss and nutritional status. This may lead to increased tolerance to anti-cancer therapies and better function maintenance, thus optimising quality of life for people with lung cancer and, in the future, other cancers.”

Read the full article

Professor David Currow is the Chief Investigator and Dr Mariana Sousa is the lead author, Principal Investigator, and coordinator for the LUANA Trial.

 

 

Dr Mariana Sousa has long brown hair and brown eyes. she is wearing a bright green top under a black jacket. She is smiling at the camera.

Dr Mariana Sousa MD, PhD, is a Chancellor's Postdoctoral Research Fellow based at the PaCCSC, IMPACCT. She is a physician and researcher with clinical and research interests in cancer-associated symptoms, including treatment-related harms and the impact of health on quality of life. Her postdoctoral fellowship focuses on better understanding cancer cachexia and identifying advances to support patients' nutritional and functional state across the cancer care continuum.
 

Byline

Dr Mariana Sousa
Share
Share this on Facebook Share this on Twitter Share this on LinkedIn
Back to IMPACCT news

Related News

Acknowledgement of Country

UTS acknowledges the Gadigal People of the Eora Nation and the Boorooberongal People of the Dharug Nation upon whose ancestral lands our campuses now stand. We would also like to pay respect to the Elders both past and present, acknowledging them as the traditional custodians of knowledge for these lands. 

University of Technology Sydney

City Campus

15 Broadway, Ultimo, NSW 2007

Get in touch with UTS

Follow us

  • Instagram
  • LinkedIn
  • YouTube
  • Facebook

A member of

  • Australian Technology Network
Use arrow keys to navigate within each column of links. Press Tab to move between columns.

Study

  • Find a course
  • Undergraduate
  • Postgraduate
  • How to apply
  • Scholarships and prizes
  • International students
  • Campus maps
  • Accommodation

Engage

  • Find an expert
  • Industry
  • News
  • Events
  • Experience UTS
  • Research
  • Stories
  • Alumni

About

  • Who we are
  • Faculties
  • Learning and teaching
  • Sustainability
  • Initiatives
  • Equity, diversity and inclusion
  • Campus and locations
  • Awards and rankings
  • UTS governance

Staff and students

  • Current students
  • Help and support
  • Library
  • Policies
  • StaffConnect
  • Working at UTS
  • UTS Handbook
  • Contact us
  • Copyright © 2025
  • ABN: 77 257 686 961
  • CRICOS provider number: 00099F
  • TEQSA provider number: PRV12060
  • TEQSA category: Australian University
  • Privacy
  • Copyright
  • Disclaimer
  • Accessibility